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Introduction
The perioperative preparation of children presenting for 
surgery aims to identify medical problems that might 
influence the outcome and to institute management 
strategies to reduce those risks. Respiratory and airway 
complications remain the most significant cause of 
morbidity and mortality in modern paediatric anaesthesia.1 
Common medical problems that are encountered in daily 
clinical practice include the child with an upper respiratory 
tract infection (URTI), allergies and asthma. The ideal 
management of these problems is discussion almost on 
a daily basis because the guidelines are not clear cut, 
and the risks may be significant and even potentially life-
threatening, particularly when managed incorrectly. Co-
morbidity involving any combination of these problems 
significantly increases the risk.2-8
Upper respiratory tract infections
Most young children have frequent URTIs. They present 
with a spectrum of signs and symptoms, depending on the 
acuity of the illness. It stands to reason that at some point, 
children will present for surgery with an acute infection, or 
soon after a recent URTI. The dilemma as to whether or 
not to cancel, proceed or postpone elective surgery has 
been a source of debate for many years.2-8 All too often, 
particularly in day-case surgery, this decision is left to the 
anaesthesiologist, who is pressured to make last-minute 
decisions by the family, the surgeon, and even hospital 
management. Late cancellations can be very disruptive to 
the surgical schedule.
In reviewing the literature, there is little uniformity or a single 
definition of an URTI that can be universally applied. Many 
researchers select certain surgical procedures and times of 
the year to ensure maximal enrolment for their study. Severe 
cases are excluded. Most of the studies were carried out 
in the “halothane and thiopentone suxamethonium” era. It 
is impossible to extrapolate from these studies when using 
drugs that are available today (sevoflurane, propofol and 
remifentanil). The clinical impression is that the risks are 
significantly reduced, but there is less evidence of that. 
Definitions also vary from one publication to the next, but 
essentially, children fall into three categories.2-8 Firstly, there 
are those who present with a fever, malaise, rhinorrhoea 
(clear or purulent), a sore or scratchy throat, sneezing, nasal 
congestion, a productive cough and chest signs, and who 
are clearly unwell. It is easy to make a decision about this 
group. Cancellation is required, unless the procedure is an 
emergency. This group is excluded from most studies.
The second group develops symptoms a day or two before 
the elective procedure. The parents call the surgeon or 
anaesthesiologist the night before. Surgery is cancelled 
and rescheduled in two weeks’ time, and the child returns 
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with minimal or no symptoms. Alternatively, a conversation 
with the parents clarifies the severity of the symptoms and 
a decision is made to re-evaluate the child on the morning 
of surgery. 
But the majority of children fall into the third category, i.e. 
those who have had a URTI with symptoms for days or 
even weeks, and who are stable or improving. Most studies 
exclude the first and second group, and only include those 
with mild URTI symptoms.
Although URTI implies an upper airway problem, the upper 
and lower airways are always involved to a variable degree. 
Viral infection damages the ciliary apparatus and mucosal 
epithelium, exposing the underlying nerve endings. 
Consequently, the airway is sensitised to the irritant effect 
of the inhalational agents and secretions. Airway smooth 
muscle activity is enhanced. In addition, a ventilation 
perfusion mismatch occurs, the closing volume increases 
and there is a reduction in functional residual capacity. 
Although the clinical symptoms resolve, usually within 
two weeks, the airway irritability may persist for up to 6-8 
weeks. It is the severity of these subclinical changes that 
ultimately influences the decision as to whether or not to 
defer surgery.3
Airway-related events, the most common adverse 
anaesthetic problem, include airway obstruction, broncho-
spasm, laryngospasm, breath holding, post-extubation 
croup, coughing, desaturation and bradycardia,3-5 and 
anecdotal reports of atelectasis, pneumonia, and even 
death.9-12 Factors that have been shown to increase the risk 
of respiratory events include more symptomatic children 
with nasal congestion and copious secretions, airway 
instrumentation in children under five years of age, surgery 
involving the airway, a history of reactive airways or snoring, 
prematurity, parental confirmation of the presence of a URTI 
and passive smoking.3,5 Infants under six months of age are 
at greatest risk.
Viral myocarditis, a particularly difficult clinical diagnosis, 
has been described in a number of sudden deaths that 
have occurred while under anaesthesia.9-12 Although rare, 
unsuspected myocarditis remains a major concern in the 
child with symptoms of a “cold”.
When making a preoperative assessment, it is important to 
exclude symptoms relating to an allergy, usually seasonal, 
or whether they are prodromal symptoms of an infectious 
disease, e.g. measles, mumps, chickenpox, rubella and 
meningococcal infection, which may put other patients or 
staff at risk. Some syndromic children may have persistent 
mucopurulent rhinitis (Down’s, Hurler’s and Hunter’s 
syndromes, cleft palate and patent ductus arteriosus) that 
may influence the decision. Rhinitis is common in these 
children, and it is important to establish whether or not 
there has been a change in the character of the secretions 
that is suggestive of an acute or chronic infection. Unilateral 
rhinorrhoea suggests unilateral nasal obstruction, e.g. a 
foreign body or polyp.
When is it safe to proceed? The ideal time to reschedule 
surgery is far from settled. Airway hypersensitivity and 
reactivity persists for up to six weeks, particularly if the lower 
airway is involved. Some authors suggest that the lower 
airways are always involved! Children may have between 
3-8 URTIs per annum. It is conceivable that if surgery is 
delayed for 4-6 weeks after each episode, there may be only 
a small window of time in which the child is asymptomatic 
and “fit” for surgery if this guideline is applied. 
Tait et al4 showed that the incidence of easily treatable 
airway complications was similar in the acutely symptomatic 
to that in subjects who had had symptoms for four weeks. 
In this study,4 which included 1 078 children aged one 
month to 18 years with mild URTI symptoms, children who 
presented for elective surgery with a recent URTI (within 
four weeks) fared as well as those with acute symptoms. 
It was concluded that with careful airway management, 
most of these children can undergo elective procedures 
without increased morbidity or long-term sequelae. There 
was no statistically significant difference in the incidence 
of laryngospasm or bronchospasm with regard to acute 
or recent URTIs with mild symptoms, compared to that in 
the asymptomatic children. Although these children have 
an increased risk of adverse respiratory events (coughing, 
breath holding and desaturation), these are easily treatable 
by experienced anaesthesiologists. 
Schreiner et al showed that nearly 2 000 cases would have 
to be cancelled to prevent 15 cases of laryngospasm in 
experienced hands.6 Delaying or cancelling the procedure 
does not significantly alter the incidence of adverse 
respiratory events. Little is gained, except to create 
inconvenience for the family and all concerned in order to 
prevent an easily treatable problem that occurs in a minority 
of patients.
Predicting which child with a URTI is likely to have an adverse 
event has recently been studied.13 Adverse respiratory 
events occurred when the children were symptomatic less 
than two weeks before the procedure. Symptoms that were 
present 2-4 weeks prior lowered the risk. Other risk factors 
included a family history of atopy, asthma and passive 
smoking.
Management of adverse respiratory events should evolve 
according to the particular circumstances, the cause, the 
available drugs and equipment, and the child’s underlying 
condition. Most events respond to simple manoeuvres, 
such as continuous positive airway pressure support; and 
simple therapeutic measures, such as bronchodilators 
which are best given intravenously, suxamethonium 
1 mg/kg, lignocaine 1 mg/kg, and endotracheal intubation 
and short-term ventilation, which should all be considered 
and used as indicated. Deepening the anaesthesia without 
compromising the child may also bring resolution.
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The ideal anaesthetic is also a matter of debate. Differences 
in study design and a lack of uniformity regarding the types 
and surgical procedures and the duration thereof, the types 
of airway instrumentation and the choice of anaesthetic for 
the child with a URTI have provided no answers. Anaesthetic 
management should aim to reduce stimulation of a 
potentially irritable airway. Propofol has major advantages 
over other agents. Isoflurane and desflurane both cause 
significant airway irritability and should be avoided. Any 
airway instrumentation is associated with more adverse 
respiratory events.6,13,14 A face mask is considered to be the 
method of choice, whenever possible.3,5,14 Laryngeal mask 
airway (LMA) intubation has fewer complications3,14 than 
endotracheal intubation, which in some studies has been 
associated with an 11-fold increase in adverse events.6 
The risk of deep extubation is no different to that of awake 
extubation.
In today’s economic climate and managed healthcare 
environment, other factors come into the equation. These 
include the distance travelled to the hospital, whether 
or not the parents have taken special leave, the attitude 
of the family, the number of previous cancellations and 
the experience of the anaesthesiologist. The impact of 
cancellation on the family can be substantial. Disruption of 
the operating schedule and the cost of staffing an operating 
room that has not been used are further considerations. 
These should not directly influence the decision, but 
realistically they often do! Ultimately, the child’s safety 
should be the primary consideration. 
Allergy 
Parents frequently indicate that their children have multiple 
drug allergies which have often not been validated. Parents 
confuse side-effects with true allergy. Potential allergic 
cross-reactivity between drugs and food is frequently 
considered to be a perioperative risk factor that needs to 
be addressed. Allergenic cross-reactivity is defined by the 
response of individual antibodies to other allergens with 
structural similarity, and can be seen in families of drugs 
or agents used during the perioperative period. “Multiple 
drug allergy syndrome” or “multiple drug hypersensitivity” 
is a clinical condition that is characterised by the propensity 
to react to chemically unrelated drugs, mainly antibiotics.15 
In most cases, the syndrome presents as acute urticaria, 
angioedema, or both, after administration of the allergenic 
compounds.15
Immediate allergic hypersensitivity reactions are triggered 
by specific immunological mechanisms mediated by 
antibodies, usually the immunoglobulin E isotype, and 
can lead to life-threatening symptoms.16 The main risk 
factor for anaphylaxis is a previous, uninvestigated severe 
immediate hypersensitivity reaction during the perioperative 
period. Neuromuscular blocking agents and antibiotics are 
the most common triggers. If possible, a history of drug-
induced anaphylaxis should be confirmed by appropriate 
evaluation.16-20
Many food allergies, e.g. egg, soy, peanuts, seafood 
and shellfish, are often mistakenly considered to be a 
contraindication to some medications, although the evidence 
for this is lacking. Many false assumptions about drug 
allergies are based on anecdotal case reports. The evidence 
suggests that egg-, soy-, or peanut-allergic patients are 
not more likely to develop anaphylaxis when exposed to 
propofol. Egg allergy is most common during childhood, 
and is usually outgrown by adulthood.21 Generally, egg-
allergic patients demonstrate immediate hypersensitivity 
to the protein in egg whites (ovomucoid and ovalbumin), 
whereas lecithin, which is not the allergenic determinant, is 
found in the egg yolk. Propofol is marketed in an oil-water 
emulsion using soybean oil (10%), and egg lecithin (1.2%) 
as the emulsifying agent. The documented anaphylactic 
reactions are caused by the isopropyl or phenol groups in 
propofol, rather than the lipid vehicle.22,23 Therefore, there is 
little or no reason to contraindicate propofol in egg-allergic 
patients.
There is also little or no reason to contraindicate propofol in 
children with a soy or peanut allergy either. Soy allergy is an 
early-onset food allergy that affects approximately 0.4% of 
children. Most children develop tolerance by late childhood.24 
Refined soy oil, such as that that is present in propofol, is 
safe for people with a soy allergy because the allergenic 
proteins are removed during the refining process. Soy and 
peanuts are both leguminous plants, and thus any cross-
reactivity should not necessitate the avoidance of propofol. 
Shellfish (crustaceans and molluscs) or fish are one of the 
most common foods that provoke severe anaphylaxis.25 The 
major allergen in fish is the muscle protein, parvalbumin, 
and tropomyosin in crustaceans. Shellfish allergens do 
not cross-react with fish allergens. Because the allergenic 
determinants for shellfish and fish are muscle proteins, and 
not other components, such as iodine, there is no reason 
to modify the anaesthetic protocol in cases of shellfish- or 
fish-allergic patients. There is no cross-reactivity between 
iodinated contrast agents, povidone iodine or seafood as 
the allergenic determinant is not iodine for any of them. 
The only contraindication to povidone iodine is a previous 
documented hypersensitivity reaction. Although the precise 
allergenic agent in povidone iodine has not been elucidated, 
it is not the iodine atom.26
Asthma
Asthma is a disorder that presents with a spectrum of airway 
obstruction, inflammation and hyper-responsiveness. It is a 
chronic inflammatory disorder of the airways that may cause 
recurrent episodes of coughing (particularly at night or in 
the early morning), wheezing, shortness of breath and chest 
tightness in susceptible individuals. Usually, these episodes 
are associated with widespread but variable airflow 
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obstruction that is often reversible, either spontaneously or 
with treatment. 
Worldwide, asthma seems to be on the increase, particularly 
in industrialised countries. It is estimated that up to 
300-million people are affected, and it is implicated in one 
of every 250 deaths. The prevalence of asthma in children, 
based on a previous diagnosis of asthma and more than one 
asthma attack in the previous year, is 5.5%. Contributing 
factors that predispose to the development and severity of 
asthma include a genetic predisposition, a history of atopy, 
exposure to airborne allergens (sensitivity to the house dust 
mite), and a history of viral respiratory infections, which are 
commonly respiratory syncytial viral or rhinovirus.27 Asthma-
triggering agents include respiratory infections, inhalants 
(animal fur, house dust mites, mould or pollen), irritants 
(cigarette smoke), temperature changes (cold air), exercise 
and anxiety. The National Asthma Education and Prevention 
Program Expert Panel Report 3 categorises asthmatics into 
groups based on the severity of their disease.27
Ultimately, asthma represents a dynamic interaction between 
the host and environmental factors. The immunological-
inflammatory pathways involved in the pathogenesis 
of asthma are complex and include lymphocytes, 
immunoglobulin E, eosinophils, neutrophils, mast cells, 
leukotrienes and cytokines. These pathways are triggered 
and modified by extrinsic and environmental factors.
The asthmatic child, even when asymptomatic, is at risk of 
perioperative morbidity (bronchospasm and anaphylaxis) 
which may progress to mortality if not recognised or poorly 
managed. This is particularly true if the child is exposed to 
allergens or other triggering agents during anaesthesia.
Especially important in the preoperative evaluation is 
assessment of disease severity, and how well the asthma 
symptoms are currently being controlled. The mainstay of 
treatment is inhaled β2 agonists (quick or long acting) by 
metered dose inhalers.28 The long-acting agents do not 
suppress inflammation and should not be used without anti-
inflammatory treatment for the control of asthma. Inhaled 
and parenteral corticosteroids are the cornerstone of therapy 
to stabilise and improve persistent asthma. Leucotriene 
modifiers inhibit the leucotriene pathway, a mediator of 
bronchoconstriction. Evidence of their beneficial effect on 
inflammation is conflicting and they are not useful in acute 
treatment.28
Information regarding medication, including oral steroid 
use, emergency visits or admissions to the hospital which 
included intravenous infusions or intubation should be 
obtained. They all provide an indication as to the severity 
of the disease. Previous anaesthetic history, presence 
of known allergies, coughing or sputum production, and 
level of activity, should also be assessed. Asthmatics 
with “atopy” are particularly predisposed to have allergic 
reactions. The anaesthesiologist should be prepared for 
the possibility of an anaphylactic reaction to allergens in 
the operating room, such as antibiotics, muscle relaxants 
or latex. When asthma is well controlled, it probably confers 
no additional risk for perioperative complications. When 
it is poorly controlled, it almost always does.28 Prior to 
elective procedures, optimal control of symptoms should be 
achieved. If not well controlled, the child should be deferred 
for additional therapy, which may need to include a short 
course of oral steroids. Oral prednisone dexamethasone 
may be needed.29,30 Patients with asthma should not have 
elective surgery during an acute viral respiratory infection 
since the risk of laryngospasm and bronchospasm is high. 
On the day of surgery, patients with asthma should continue 
their medications as usual. Inhaled β2 agonists should be 
given 1-2 hours prior to surgery. Premedication is usually 
indicated (oral midazolam (0.5-1 mg/kg) since anxiety may 
precipitate an acute episode. Systemic corticosteroids use 
in the previous six months is an indication that stress dose 
coverage is needed to avoid an adrenal crisis. High-dose 
inhaled corticosteroids use may also indicate perioperative 
stress dose coverage in certain patients. 
The anaesthetic plan should provide a balance between 
suppression and avoidance of bronchospasm, with the 
usual goals of patient safety, comfort and a quiet surgical 
field. Drugs that release histamine from mast cells should 
be avoided. These include thiopentone, many muscle 
relaxants (atracurium, d-tubocurare and mivacurium), and 
analgesics (morphine). Ketamine is ideal since it produces 
smooth muscle relaxation and bronchodilatation, both 
directly and via release of catecholamines. Propofol 
causes profound depression of airway reflexes, and when 
compared to thiopentone, there is a significantly lower 
incidence of wheezing following intubation.31 The alpha 
2 agonist, dexmedetomidine, has a favourable profile, 
including anxiolysis, sympatholysis and drying of secretions 
without respiratory depression,26 but is still “off label”.
Airway instrumentation under a light level of anaesthesia 
should be avoided. Avoiding intubation by using a mask or 
LMA for appropriate cases is optimal. An inhaled β2 agonist 
immediately prior to induction may decrease the risk of 
bronchospasm that can occur with intubation.32 Topical 
local anaesthesia (lignocaine 5 mg/kg maximum) is also 
useful as it obtunds the sensory loop of the reflex arc, thus 
preventing reflex bronchoconstriction. However, an aerosol 
spray containing a propellant in addition to lignocaine, may 
trigger airway reactivity. A squirt of lignocaine directed onto 
the upper airway from a syringe, or intravenous lignocaine, 
is preferable.
Sevoflurane is the agent of choice for inhalational induction 
for a variety of reasons. It has a positive bronchodilating 
effect, and a lower incidence of laryngospasm and cardiac 
dysrhythmias than that of halothane, isoflurane or other 
volatile anaesthetics. Propofol infusion can also be used 
for the maintenance of anaesthesia. Desflurane, an airway 
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irritant, may cause an elevation in airway resistance in 
children with airway susceptibility, and should not be used. 
Intraoperatively, bronchospasm can be provoked by 
laryngoscopy, tracheal intubation, airway suctioning, 
cold-inspired gases and tracheal extubation. Airway tone 
is increased by vagal stimulation caused by endoscopy, 
peritoneal or visceral stretch.26 Inhalation agents and 
gases should be humidified to prevent inspissation of the 
already-thick secretions. Tracheal suctioning should be 
performed only when the child is deeply anaesthetised, or 
when there is topical anaesthesia. The mode of ventilation 
should be low-inflating pressure, with prolonged expiratory 
time. Potentially, deep extubation avoids the risk of 
bronchospasm from coughing on the endotracheal tube. 
The reversal of neuromuscular blockade with neostigmine 
does not cause bronchospasm if atropine or glycopyrrolate 
are administered concurrently. 
Regional anaesthetic techniques are useful for postoperative 
analgesia. There are concerns about the use of nonsteroidal 
anti-inflammatory drugs (NSAIDs). Despite the fact that 
many asthmatics have used ibuprofen without a problem, 
a recent meta-analysis suggests that NSAIDs should be 
avoided in those with a history of an adverse response to a 
NSAID, and in those who have not been previously exposed 
to one.33
Conclusion 
The anaesthesiologist should focus on signs and symptoms 
that quantify respiratory status when conducting a 
preoperative assessment of a child with a URTI or asthma. 
Parents are useful barometers of their child’s condition 
and any day-to-day changes from baseline. Children with 
coexisting pulmonary disease, particularly reactive airway 
disease, and infants under six months of age with an active 
URTI, are at greater risk. Food or drug allergies may be 
additional confounders. As the world becomes increasingly 
polluted and industrialised, it can be expected that more 
allergens will impact on the daily lives of patients.
The final decision to proceed with surgery should rest with 
the individual anaesthesiologist and will be influenced by 
his or her ability, experience and comfort level in managing 
predictable complications in a child with URTI or asthma. 
Clearly, those with more experience may be prepared to 
proceed with younger patients with or without additional 
pathology, while others with less experience may not. 
Whatever the decision, the child’s safety remains paramount! 
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